Russian pharmaceutical and medical industry companies can be subsidized for partial reimbursement
Russian pharmaceutical and medical industry companies can be subsidized for partial reimbursement. Such a support measure is implemented within the state program of the Russian Federation «Development of the pharmaceutical and medical industry» for 2013-2020. The state aid measures are aimed at stimulating investment activities of Russian manufacturers to create, expand and revamp their facilities.
A list of projects subject to subsidies granting to pharmaceutical and medical industry companies is as follows:
- organization and carrying-out of clinical trials of medicinal drugs (see details at https://gisp.gov.ru/support-measures/list/6616939/);
- organization of manufacture of medicinal drugs and (or) pharmaceutical ingredients (see details at https://gisp.gov.ru/support-measures/list/6616940/);
- development of improved equivalents for innovative medicinal drugs (see details at https://gisp.gov.ru/support-measures/list/6987532/);
- organization and carrying-out of clinical trials of implantable medical devices (see details at https://gisp.gov.ru/support-measures/list/6616912/);
- organization of manufacture of medical devices (see details at https://gisp.gov.ru/support-measures/list/6616913/);
Experts of FSI «SID & GP» are open for providing clarifications on the procedure and terms of subsidizing. For this, send e-mails to: consultans@gilsinp.ru.
Other materials
- Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products
- Vladislav Shestakov took part in the 8th International Pharmaceutical Congress Russia – Nicaragua “Evolution of Production Potential: Localization of Production to Strengthen the International Health Care System”
- The 31st N.A. Semashko Russian Pharmaceutical Forum was held in Saint Petersburg on May 14-15, 2024 with the support of the FSI “SID&GP” of the Ministry of Industry and Trade of Russia
- The expansion of cooperation in the pharmaceutical and medical industries discussed at the INNOPROM. Central Asia international exhibition
- FSI “SID&GP” participated in the workshop on “Radiopharmaceuticals: production, quality, safety in 2024”